Bruce Booth
InvestorUnicorn founderChair at Kymera Therapeutics · Partner at Atlas Venture · Board director at Vigil Neuroscience · Chairman at HotSpot Therapeutics
Wellesley, MA
Writes $500K – $5M checks · typically $2M
FoundedKymera Therapeutics$2.3B
Find your path to Bruce
87 people in our graph share verified history with Bruce — schools, employers, funds. One of them is your warm intro.
About
Bruce Booth is a partner at Atlas Venture focused on the discovery and development of novel medicines and therapeutic platforms. He joined Atlas in 2005 after working as a consultant at McKinsey & Company and as an investor for Caxton Health Holdings. He holds a D.Phil. in molecular immunology from Oxford University, which he attended as a British Marshall Scholar, and a BS in biochemistry from The Pennsylvania State University.
Contact· published on Bruce's own website
Invests in
Biotech
Board director at Vigil Neuroscience
Intro paths
In turn, Bruce can intro founders to Vigil Neuroscience's investors below.
Chairman at HotSpot Therapeutics
Intro paths
In turn, Bruce can intro founders to HotSpot Therapeutics's investors below.
HotSpot Therapeutics's investors · 8
.jpeg){kind=logo}
Chair at Kymera Therapeutics
Intro paths
In turn, Bruce can intro founders to Kymera Therapeutics's investors below.
Kymera Therapeutics's investors · 12
Co-founders at Kymera Therapeutics
Investments
Board seats
AvilaHotspot TherapeuticsKymera TherapeuticsLifordi ImmunotherapeuticsLysosomal TherapeuticsMatchpoint TherapeuticsNimbus LakshmiPadlock TherapeuticsRodin TherapeuticsSionna TherapeuticsSpolia TherapeuticsStromedixVigil Neuroscience
Investor
Arkuda TherapeuticsAvila TherapeuticsAvrobioBicycle TherapeuticsCogent BiosciencesHotSpot TherapeuticsKymera TherapeuticsLarimar TherapeuticsLifordi ImmunotherapeuticsLysosomal TherapeuticsMagenta TherapeuticsMatchpoint TherapeuticsNimbus TherapeuticsNumeratePadlock TherapeuticsQuartet MedicineQuench BioRodin TherapeuticsSionna TherapeuticsStromedixViridian Therapeutics (Formerly MiRagen Therapeutics)
Sources: the firm's website · curated public sources.
Colleagues at Atlas Venture
Network7
Investors connected to Bruce in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Bruce Booth?
- Bruce Booth is a partner at Atlas Venture focused on the discovery and development of novel medicines and therapeutic platforms. He joined Atlas in 2005 after working as a consultant at McKinsey & Company and as an investor for Caxton Health Holdings. He holds a D.Phil. in molecular immunology from Oxford University, which he attended as a British Marshall Scholar, and a BS in biochemistry from The Pennsylvania State University.
- Where does Bruce Booth work?
- Bruce Booth is Chair of Kymera Therapeutics and Partner at Atlas Venture and Board director at Vigil Neuroscience and Chairman at HotSpot Therapeutics.
- What does Bruce Booth invest in?
- Bruce Booth invests in Biotech.
- What check size does Bruce Booth write?
- Bruce Booth typically writes checks of $500K – $5M.
- What companies did Bruce Booth found?
- Bruce Booth founded Kymera Therapeutics.
- What boards does Bruce Booth sit on?
- Bruce Booth holds tracked board seats at Avila, Hotspot Therapeutics, Kymera Therapeutics, Lifordi Immunotherapeutics, Lysosomal Therapeutics, Matchpoint Therapeutics, Nimbus Lakshmi, Padlock Therapeutics, Rodin Therapeutics, Sionna Therapeutics.
- What companies has Bruce Booth invested in?
- Investments tracked here include Arkuda Therapeutics, Avila Therapeutics, Avrobio, Bicycle Therapeutics, Cogent Biosciences, HotSpot Therapeutics, Kymera Therapeutics, Larimar Therapeutics, Lifordi Immunotherapeutics, Lysosomal Therapeutics, Magenta Therapeutics, Matchpoint Therapeutics, and 9 more.